APOOL expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 7.617900E-03 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.882370E-02 |
Normal-vs-Stage2 |
2.095700E-02 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.613420E-01 |
Stage1-vs-Stage2 |
4.068600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.891000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.396000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.104100E-02 |
Normal-vs-AfricanAmerican |
2.488600E-01 |
Normal-vs-Asian |
2.505200E-01 |
Caucasian-vs-AfricanAmerican |
2.020900E-04 |
Caucasian-vs-Asian |
6.791800E-01 |
AfricanAmerican-vs-Asian |
2.712600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.465900E-02 |
Normal-vs-Female |
1.716130E-02 |
Male-vs-Female |
4.056000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.619800E-01 |
Normal-vs-Extreme_Weight |
7.787700E-02 |
Normal-vs-Obese |
5.591500E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.666600E-01 |
Normal_Weight-vs-Obese |
1.121020E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.869820E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.064200E-03 |
Normal-vs-Age(41-60Yrs) |
9.613800E-02 |
Normal-vs-Age(61-80Yrs) |
1.288820E-01 |
Normal-vs-Age(81-100Yrs) |
2.792000E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.563600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.037800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.807950E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.134200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.780800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.001200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.918800E-01 |
Normal-vs-Grade 3 |
6.296000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.131400E-01 |
Grade 2-vs-Grade 4 |
7.918800E-01 |
Grade 3-vs-Grade 4 |
6.296000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.110400E-02 |
Normal-vs-N1 |
1.900220E-02 |
N0-vs-N1 |
9.857400E-01 |
|
|